ReLive is a pioneering global biotech company specializing in regenerative medicine. Founded in 2021 by experts, we develop and manufacture innovative regenerative therapies to address unmet clinical needs in orthopedics worldwide. With global headquarters in Boston and manufacturing facilities in Germany and China, ReLive is strategically positioned to lead in regenerative therapy. Our vision is to transform lives through science, making a lasting difference for patients globally.
